Characterization of HPV and host genome interactions in primary head and neck cancers

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 43, 2014, Pages 15544-15549

  Parfenov, Michael ^a   Pedamallu, Chandra Sekhar ^b,c   Gehlenborg, Nils ^c,d   Freeman, Samuel S ^c   Danilova, Ludmila ^e   Bristow, Christopher A ^f   Lee, Semin ^d   Hadjipanayis, Angela G ^a   Ivanova, Elena V ^b   Wilkerson, Matthew D ^g   Protopopov, Alexei ^f   Yang, Lixing ^d   Seth, Sahil ^f   Song, Xingzhi ^f   Tang, Jiabin ^f   Ren, Xiaojia ^a   Zhang, Jianhua ^f   Pantazi, Angeliki ^a   Santoso, Netty ^a   Xu, Andrew W ^d   Mahadeshwar, Harshad ^f   Wheeler, David A ^h   Haddad, Robert I ^b   Jung, Joonil ^c   Ojesina, Akinyemi I ^b,c   Issaeva, Natalia ⁱ   Yarbrough, Wendell G ⁱ   Hayes, D Neil ^g   Grandism, Jennifer R ^j   El Naggar, Adel K ^f   Meyerson, Matthew ^a,b,c   Park, Peter J ^d   Chin, Lynda ^c,f   Seidman, J G ^a   Hammerman, Peter S ^b,c   Kucherlapati, Raju ^a   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d Harvard Medical School Center for Biomedical Informatics   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Cancer; Genome rearrangement; Head and neck; Integration sites; Papilloma virus

Indexed keywords

ARTICLE; DNA SEQUENCE; GENE DOSAGE; GENOME; HEAD AND NECK CANCER; HUMAN; HUMAN GENOME; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; MAJOR CLINICAL STUDY; METHYLATION; NONHUMAN; RNA SEQUENCE; RNA TRANSCRIPTION; VIRUS CELL INTERACTION; VIRUS GENOME; WART VIRUS; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HOST PATHOGEN INTERACTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRIDAE; PHYSIOLOGY; TUMOR GENE; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

BASE SEQUENCE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENOME, HUMAN; HEAD AND NECK NEOPLASMS; HOST-PATHOGEN INTERACTIONS; HUMANS; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; VIRUS INTEGRATION;

EID: 84908261808     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1416074111     Document Type: Article

References (53)

1. Joseph AW, D'Souza G (2012) Epidemiology of human papillomavirus-related head and neck cancer. Otolaryngol Clin North Am 45(4):739-764.
2. O'Rorke MA, et al. (2012) Human papillomavirus related head and neck cancer survival: A systematic review and meta-analysis. Oral Oncol 48(12):1191-1201.
3. D' Souza G, et al. (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356(19):1944-1956.
4. Gillison ML, et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709-720.
5. Goon PK, et al. (2009) HPV & head and neck cancer: A descriptive update. Head Neck Oncol 1:36.
6. Rautava J, Syrjänen S (2012) Biology of human papillomavirus infections in head and neck carcinogenesis. Head Neck Pathol 6(Suppl 1):S3-S15.
7. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D (1999) Head and neck cancer in nonsmokers: A distinct clinical and molecular entity. Laryngoscope 109(10):1544-1551.
8. Chaturvedi AK, et al. (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294-4301.
9. Gillison ML, et al. (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100(6):407-420.
10. Agrawal N, et al. (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333(6046):1154-1157.
11. Stransky N, et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333(6046):1157-1160.
12. Akagi K, et al. (2014) Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res 24(2):185-199.
13. Walter V, et al. (2013) Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS ONE 8(2):e56823.
14. Lechner M, et al. (2013) Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors. Genome Med 5(5):49.
15. Wilson GA, et al. (2013) Integrated virus-host methylome analysis in head and neck squamous cell carcinoma. Epigenetics 8(9):953-961.
16. Münger K, Phelps WC, Bubb V, Howley PM, Schlegel R (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63(10):4417-4421.
17. de Freitas AC, Coimbra EC, Leitão MdaC (2014) Molecular targets of HPV oncoproteins: Potential biomarkers for cervical carcinogenesis. Biochim Biophys Acta 1845(2):91-103.
18. Tommasino M (2014) The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol 26:13-21.
19. Grabowska AK, Riemer AB (2012) The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J 6:249-256.
20. DiMaio D, Petti LM (2013) The E5 proteins. Virology 445(1-2):99-114.
21. Wentzensen N, Vinokurova S, von Knebel Doeberitz M (2004) Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 64(11):3878-3884.
22. Moody CA, Laimins LA (2010) Human papillomavirus oncoproteins: Pathways to transformation. Nat Rev Cancer 10(8):550-560.
23. Korzeniewski N, Spardy N, Duensing A, Duensing S (2011) Genomic instability and cancer: Lessons learned from human papillomaviruses. Cancer Lett 305(2):113-122.
24. Pett MR, et al. (2004) Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res 64(4):1359-1368.
25. Peter M, et al. (2010) Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J Pathol 221(3):320-330.
26. Peter M, et al. (2006) MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 25(44):5985-5993.
27. Schmitz M, et al. (2012) Loss of gene function as a consequence of human papillomavirus DNA integration. Int J Cancer 131(5):E593-E602.
28. Kraus I, et al. (2008) The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res 68(7):2514-2522.
29. Xu B, et al. (2013) Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas. PLoS ONE 8(6):e66693.
30. Dürst M, Croce CM, Gissmann L, Schwarz E, Huebner K (1987) Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 84(4):1070-1074.
31. Kim SH, et al. (2007) HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 120(7):1418-1425.
32. Hafkamp HC, et al. (2003) A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 107(3):394-400.
33. Kostic AD, et al. (2011) PathSeq: Software to identify or discover microbes by deep sequencing of human tissue. Nat Biotechnol 29(5):393-396.
34. Suwaki N, Klare K, Tarsounas M (2011) RAD51 paralogs: Roles in DNA damage signalling, recombinational repair and tumorigenesis. Semin Cell Dev Biol 22(8):898-905.
35. Kabbout M, et al. (2013) ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer. Clin Cancer Res 19(13):3383-3395.
36. Kumar-Sinha C, Tomlins SA, Chinnaiyan AM (2008) Recurrent gene fusions in prostate cancer. Nat Rev Cancer 8(7):497-511.
37. Frigola X, et al. (2011) Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma. Clin Cancer Res 17(7):1915-1923.
38. Steidl C, et al. (2011) MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471(7338):377-381.
39. Imielinski M, et al. (2012) Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150(6):1107-1120.
40. Ke N, et al. (2004) Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 64(22):8208-8212.
41. Nandan MO, et al. (2008) Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology 134(1):120-130.
42. Cancer Genome Atlas Research Network (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489(7417):519-525.
43. Lechner M, et al. (2013) Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Med 5(2):15.
44. Lleras RA, et al. (2013) Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma. Clin Cancer Res 19(19):5444-5455.
45. Sellar GC, et al. (2001) BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression. Cancer Res 61(19):6977-6981.
46. Nguyen HH, et al. (2012) IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility. Hum Mol Genet 21(9):2076-2085.
47. Lu B, Asara JM, Sanda MG, Arredouani MS (2011) The role of the transcription factor SIM2 in prostate cancer. PLoS ONE 6(12):e28837.
48. Konno-Shimizu M, et al. (2013) Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: A novel suggestion on gastric tumorigenesis. PLoS ONE 8(2):e56766.
49. Kostareli E, et al. (2013) HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J Clin Invest 123(6):2488-2501.
50. Pett M, Coleman N (2007) Integration of high-risk human papillomavirus: A key event in cervical carcinogenesis? J Pathol 212(4):356-367.
51. Lui VW, et al. (2013) Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov 3(7):761-769.
52. Ojesina AI, et al. (2014) Landscape of genomic alterations in cervical carcinomas. Nature 506(7488):371-375.
53. Su Y, et al. (2014) MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s. Neuroreport 25(1):12-17.